The launch event of the RETHINKING Alzheimer's disease White Paper, calling for change in Alzheimer's care, will take place virtually on 24 January 2023 at 12:30 - 14:00. About Alzheimer's disease Alzheimer’s disease (AD) is a neurodegenerative disease that progresses in stages, beginning with a long silent phase before symptoms occur. It is the underlying cause [...]
The launch event of the RETHINKING Alzheimer’s disease White Paper, calling for change in Alzheimer’s care, will take place virtually on 24 January 2023 at 12:30 – 14:00. The European Brain Council (EBC), in collaboration with the European Federation of Pharmaceutical Industries and Associations (EFPIA), will present its White Paper “RETHINKING Alzheimer’s disease: Detection and diagnosis“. This paper is [...]
Learn about when and how psychedelic-assisted therapy becomes a reality. What are the legislative and regulatory roadblocks, and how Chris Koddermann (ITPRI - Reschedule Psilocybin), Amy Emerson (MAPS PBC), Tadeusz Hawrot (PAREA - Psychedelic Access and Research European Alliance) and Graham Pechenik (Calyx Law) are taking them down? When will psychedelic-assisted therapy become a reality [...]